Health
Inhaled steroids reduce SARS-CoV-2-related genes in COPD – News-Medical.Net
A new study published on the preprint server medRxiv* aims to explore the effects of treatment with ICS on the expression of specific genes related to SARS-CoV-2 infection in bronchial epithelial cells in a prospective interventional design.
The chronic lung condition called COPD (chronic obstructive pulmonary disease) increases the risk of severe COVID-19.
Inhaled corticosteroids (ICS) are commonly prescribed to stabilize respiratory function in these patients, but the associated risk of bacterial infection has daunted some healthcare professionals from using them. Moreover, in vitro, studies show that they have an immunosuppressive effect on cells exposed to viruses. There is no evidence to reveal the effects of ICS on either sus…
-
General20 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News23 hours agoTips to improve engagement – Proctor
-
Noosa News22 hours agoPolice appeal for information over suspected link in torture and murder cases
-
Noosa News16 hours agoWorking for someone else made it hard to care for my daughter. So I quit